Close Menu
    What's Hot

    Morrisons Retirement Saver Plan Completes Bulk Purchase Annuity Buy-In With Aviva

    28 May 2025

    Yellow Pages Limited Purchases Group Annuity Contracts From BMO Life Assurance Company

    22 May 2025

    Life ILS Conference 2025

    20 May 2025
    Facebook X (Twitter) Instagram
    Instagram LinkedIn X (Twitter)
    Life Risk News
    • Home
    • Features

      New Data Shows the Extent to Which American Seniors Are Missing Out by Lapsing or Surrendering their Life Insurance Policy

      14 May 2025

      Buy-Ins To Buy-Outs Appear Stalled As Deal Complexity, Administration Resources Pose Obstacles

      14 May 2025

      Is Servicing an Overlooked Source of Life Settlement Alpha?

      14 May 2025

      Q&A: Shelly Beard, Managing Director, WTW

      14 May 2025

      Longevity Tech to Emerge as Distinct Sub-Sector of Venture Capital Market?

      14 May 2025
    • Commentary

      UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

      14 May 2025

      The Power of Uncorrelated Diversification During Market Volatility

      14 May 2025

      Overseeing BPA Growth Safely

      14 May 2025

      Could Climate Change Cause the Buy-In Market To Collapse?

      10 April 2025

      ICS vs Solvency II: Comparing Risk Corrections for Illiquid Liabilities

      10 April 2025
    • Events
    • Magazine
    • News

      Morrisons Retirement Saver Plan Completes Bulk Purchase Annuity Buy-In With Aviva

      28 May 2025

      Yellow Pages Limited Purchases Group Annuity Contracts From BMO Life Assurance Company

      22 May 2025

      Andrew Limited Pension and Life Assurance Plan Completes Bulk Annuity Transaction With Aviva

      15 May 2025

      Life Insurance Settlement Association Publishes Latest Market Data Collection Survey Results

      13 May 2025

      UK Aggregate Defined Benefit Pension Fund Surplus Down Again in April

      12 May 2025
    Subscribe
    Life Risk News
    Home » Covid-19 Excess Mortality Analysis

    Covid-19 Excess Mortality Analysis

    Commentary 14 September 2023John LynchBy John Lynch
    Twitter LinkedIn Email
    Share
    Twitter LinkedIn Email

    The World Health Organization (WHO) declared an end to the public health emergency due to COVID-19 on May 11th of this year. The Centers for Disease and Control (CDC) tracks all causes of death and has published provisional summary for 2022 deaths including COVID-19 related deaths. The data below highlights the sporadic increase in COVID-19 deaths during the multiple waves of the pandemic.

    It remains to be seen if a new COVID-19 wave will emerge in late 2023, but all indications point to COVID now being a lower-level endemic.

    Source: https://covid.cdc.gov/covid-data-tracker/#trends_weeklydeaths_select_00

    COVID-19 was associated with approximately 246,000 deaths in the United States during January-December 2022. The above weekly graph from the CDC ¹ shows provisional COVID-19 deaths on a standalone basis since the start of the pandemic. It highlights five separate and distinct waves from 2020 through to end of April 2022. Since May 2022, the trend has oscillated between 1,500 and 4,000 COVID-19 deaths per week. But since the start of this year, 2023 has been trending towards zero.

    The methodology for analyzing the impact of COVID-19 for this report is using a simplified approach of comparing the actual death counts for each month of the pandemic vs. same month in 2019, prior to the pandemic. Note: this is not an actual to expected analysis, as there is no mortality table assumption involved; subsequent reports in this series will have Actual to Expected analyses. This analysis is trying to identify the excess mortality assuming similar mortality trends extending from 2019 into future years.

    The graph below highlights the higher winter deaths and lower summer deaths in the light blue color, which has been evident for decades in population data. This phenomenon accounts for roughly a 7-10% increase in winter deaths vs. summer deaths and was evident in all 3 datasets. COVID-19 had waves that occurred in all seasons, coming and going for different lengths in different time periods across various quarters. Therefore, analyzing monthly instead of quarterly or annual allows for a better focused analysis of the true excess mortality due to COVID-19 within each wave. Monthly comparisons allow for a lateral comparison neutralizing seasonal impacts of mortality.

    Source: https://covid.cdc.gov/covid-data-tracker/#trends_weeklydeaths_select_00

    The non-COVID excess deaths in 2022 shown above in gray are running 7% higher than 2019 pre-pandemic levels. This is being driven by higher heart disease, diabetes-related diseases, and accidents such as suicide and overdose. These appear to be indirect, secondary impacts relating to the pandemic and downstream effects of lost wages and loneliness which were more impactful on the lower end of the economic demographics. This highlights the incremental impact of both official COVID-19 recorded deaths and other excess deaths which may or may not be due to secondary impacts of COVID-19.

    The question remains, how many (if any) of these secondary impacts will migrate up the economic ladder into the life settlement risk pool?

    Life Settlement Mortality

    Using the CDC Wonder database is great for monitoring population mortality. The life insurance subset is generally a higher economic demographic subset with longer than average life expectancies (We will explore this effect more in a future report).

    The life settlement pool is a subset of life insurance pool, and the ‘standard’ life expectancy is even longer. Hence one might expect the effect of COVID-19 to follow similar patterns. Let’s dig into our Longevity mortality datasets to see what extent COVID-19 impacted similar and different as compared to population mortality.

    The below graph takes data that was created from the Fasano life settlement underwritings for the Life Expectancy (LE) product, covering over 65,000 lives underwritten by Fasano during the past 22 years.

    Deaths are plotted by month and compared to the same number of deaths in 2019, the year prior to COVID-19, as a baseline. Significant excess deaths are assumed to be due to COVID-19. The data shows significant spikes in mortality during the 1st and 2nd waves of COVID-19, and one significant month of excess deaths during the early stages of the Omicron wave. September of 2021 had the largest month of increased deaths; +49% vs. 2019 same month.

    Source: https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm as of 8/2023

    A summary of relative impact for each wave of the COVID-19 pandemic range from 20-30% in line with the population COVID-19 increases.

    Additional deaths from October 2021 forward can be attributable to the aging of the dataset.

    The below graph takes data that was created from the TwentyFirst underwritings for the Life Expectancy (LE) product, covering over 98,000 lives underwritten by TwentyFirst during the past 20 years.

    The actual life settlement deaths in the 21st underwriting dataset do not indicate any recent excess in the past 20 months compared to the first year of the COVID-19 pandemic. The pronounced spikes in March 2020 and winter of 2020/21 highlight COVID-19’s impact during the first two waves of the pandemic.

    A summary of relative impact for each wave of the COVID-19 pandemic range from 20-30% in line with the population COVID-19 increases.

    Similarly, the additional deaths from October 2021 forward can be attributable to the aging of the dataset.

    Conclusion

    Excess mortality due to COVID-19 hit the life settlement industry by the same scale as the population excess mortality for the early stages of the pandemic. By the end of 2021, the excess mortality effect has mostly subsided versus excess mortality persisted for the population well into 2023.

    Based upon the review of COVID-19 mortality since inception of the pandemic to present day, it has been determined to not make assumption changes to the base mortality tables for our LE businesses due to COVID-19. Small debit adjustments have been made to account for long-COVID and other active COVID-19 conditions on a case-by-case basis.

    John Lynch is Director of Actuarial & Underwriting Services at Longevity Holdings


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association

    2023 - September Health Longevity and Mortality Trends Volume 2 Issue 9 - September 2023
    Share. Twitter LinkedIn Email

    Related Posts

    UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

    14 May 2025

    The Power of Uncorrelated Diversification During Market Volatility

    14 May 2025

    Overseeing BPA Growth Safely

    14 May 2025

    Could Climate Change Cause the Buy-In Market To Collapse?

    10 April 2025

    Comments are closed.

    Most Popular

    New Data Shows the Extent to Which American Seniors Are Missing Out by Lapsing or Surrendering their Life Insurance Policy

    14 May 2025

    Buy-Ins To Buy-Outs Appear Stalled As Deal Complexity, Administration Resources Pose Obstacles

    14 May 2025

    Is Servicing an Overlooked Source of Life Settlement Alpha?

    14 May 2025

    UK Life Insurers to Benefit from Robust Bulk Annuity Market in 2025

    14 May 2025
    Ad

    Your trusted source for capital markets participation in Life Risk

    X (Twitter) Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Copyright Notice
    • Terms and Conditions
    • Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT